Gastric Cancer Prognosis Varies by Age and Gender: Study Highlights Need for Personalized Treatment Strategies

A study of 14,739 patients at Bundang Seoul National University Hospital reveals that stomach cancer prognosis varies significantly by age and gender, with women under 50 facing poorer outcomes than their male counterparts. Researchers found that hormone-driven differences in tumor types—specifically the higher prevalence of diffuse-type gastric cancer in younger women—necessitate age-specific diagnostic and treatment strategies.

Did You Know? Among the patients studied between 2003 and 2023, female stomach cancer patients were generally diagnosed at a younger age than men, highlighting a distinct clinical profile for women across different life stages.

Why Age and Gender Impact Stomach Cancer Prognosis

While stomach cancer is frequently associated with men, it remains the fifth most common cancer among women in South Korea. Research led by Professors Kim Na-young and Choi Yong-hoon suggests that the inconsistency in previous survival data for women is likely rooted in biological changes occurring throughout a woman’s life cycle. As estrogen and other sex hormones fluctuate during a woman’s 50s and 60s, these shifts influence both cancer development and treatment response.

The study found that while there was no significant difference in “gastric cancer-specific survival” between genders overall, age creates a sharp divide. Women under 50 showed lower survival rates compared to men, whereas women over 60 experienced better outcomes than their male peers. This suggests that a one-size-fits-all approach to diagnosis may overlook critical, age-dependent risks.

The Role of Tumor Type in Patient Outcomes

The primary factor influencing these survival differences is the “diffuse type” of stomach cancer, where cells spread across the stomach wall rather than forming a single mass. The research team observed that women have a higher proportion of this aggressive, diffuse-type cancer compared to men, particularly in the under-50 age group.

In contrast, men show a rapid shift toward the “intestinal type” of cancer—which typically presents as a distinct mass—as they age. By age 50, over 60% of stomach cancers in men are of the intestinal type. Women, however, show a much slower transition, only reaching similar levels of intestinal-type prevalence by age 70. Experts believe this may be linked to estrogen receptors, where the alpha receptor is associated with the development of diffuse-type cancer, while the beta receptor may help suppress the intestinal type.

Expert Insight: The disparity in how different tumor types respond to hormonal environments suggests that clinical management must move beyond simple gender-based classifications. By acknowledging that younger women are at higher risk for harder-to-treat diffuse cancers, clinicians can better prioritize screening for those with specific risk factors, such as a family history or Helicobacter pylori infection.

What May Happen Next in Clinical Screening

Given that women under 40 are currently excluded from national cancer screening programs, researchers suggest that the current system may be missing a vulnerable population. A possible next step involves a policy shift toward lowering the age threshold for national gastric cancer screenings.

Challenges, Prognosis, and Future Directions for Peritoneal Gastric Cancer

Furthermore, institutions may look to integrate specialized testing for high-risk groups to improve early detection. This could include increased support for Pepsinogen II testing and Helicobacter pylori serum tests, which could help identify patients requiring more intensive monitoring before symptoms appear.

Frequently Asked Questions

Q: Why do younger women often have a worse prognosis for stomach cancer?
A: The study indicates that women under 50 have a higher proportion of diffuse-type stomach cancer, which is known to be more difficult to detect and treat compared to the intestinal type more common in older men.

Q: How does age affect the survival rate for women?
A: Researchers found that women under 50 have lower survival rates than men, but this trend reverses after age 60, where women show a better prognosis than men of the same age.

Q: What is the suggested strategy for improving early detection?
A: The research team recommends a more tailored approach that accounts for age and tissue type, including potential policy discussions on lowering the age for national cancer screenings and implementing specialized blood tests for high-risk individuals.

How might these findings change the way healthcare providers prioritize screening for younger patients with a family history of stomach cancer?